Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Predictive Oncology Inc. (POAI : NSDQ)

• Company Description    Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. Number of Employees: 124

• Price / Volume Information    Yesterday's Closing Price: $0.95 Daily Weekly Monthly 20 Day Moving Average: 123,667 shares Shares Outstanding: 10.89 (millions) Market Capitalization: $10.35 (millions) Beta: 1.37 52 Week High: $3.06 52 Week Low: $0.55 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 9.20% 7.28% 12 Week 5.56% -4.12% Year To Date 15.85% 3.44%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 91 43RD STREET SUITE 110 - PITTSBURGH,PA 15201 USA ph: 412-432-1500 fax: - mmoyer@lifesciadvisors.com https://predictive-oncology.com

• General Corporate Information    Officers Raymond F. Vennare - Chief Executive Officer Josh Blacher - Interim Chief Financial Officer Chuck Nuzum - Director Daniel E. Handley - Director Veena Rao - Director Peer Information Predictive Oncology Inc. (HLIS) Predictive Oncology Inc. (AZTA) Predictive Oncology Inc. (APYI) Predictive Oncology Inc. (RNVA) Predictive Oncology Inc. (HMSY) Predictive Oncology Inc. (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 74039M309 SIC: 3842 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/11/25 Share - Related Items Shares Outstanding: 10.89 Most Recent Split Date: 4.00 (0.05:1) Beta: 1.37 Market Capitalization: $10.35 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.09 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.13 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/11/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 6.22 EPS Growth vs. Year Ago Period: 67.65% vs. Previous Quarter: 31.25% Sales Growth vs. Year Ago Period: -98.92% vs. Previous Quarter: -97.27% ROE 06/30/25 - - 03/31/25 - -722.01 12/31/24 - -494.06 ROA 06/30/25 - -167.23 03/31/25 - -142.50 12/31/24 - -145.45 Current Ratio 06/30/25 - 0.32 03/31/25 - 0.76 12/31/24 - 0.62 Quick Ratio 06/30/25 - 0.31 03/31/25 - 0.75 12/31/24 - 0.51 Operating Margin 06/30/25 - -546.76 03/31/25 - -530.94 12/31/24 - -543.74 Net Margin 06/30/25 - -587.31 03/31/25 - -560.98 12/31/24 - -562.62 Pre-Tax Margin 06/30/25 - -546.76 03/31/25 - -493.64 12/31/24 - -668.72 Book Value 06/30/25 - -0.16 03/31/25 - -0.02 12/31/24 - -0.03 Inventory Turnover 06/30/25 - 3.49 03/31/25 - 2.26 12/31/24 - 1.74 Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - -

Powered by Zacks Investment Research ©